Patrick Daly

DocwireNews

Researchers from the Department of Medical Physics at Instituto Zunino &ndash; Fundaci&oacute;n Marie Curie in C&oacute;rdoba, Argentina, set out to construct a knowledge-based <a href="https://my.clevelandclinic.org/health/treatments/17626-volumetric-modulated-arc-therapy-vmat#:~:text=Volumetric%20Modulated%20Arc%20Therapy%20(VMAT)%20uses%20photons%20(W%2D,a%20complete%20three%2Ddimensional%20manner.">volumetric modulated arc therapy</a> (VMAT) planning model to enable the treatment of breast cancer without lymph node irradiation. Their article, published in the Journal of Medical Physics, reported that they successfully implemented two RapidPlan&trade; (RP) models for breast cancer treatment that reduced planning time and improved treatment planning efficiency while ensuring high-quality treatment plans.According to the study&rsquo;s lead author, Oscar Abel Apaza Blanco, the researchers found that &ldquo;the RP plans performed are dosimetrically equivalent to [manual plans (MP)] generated by expert physicists and dosimetrists,&rdquo; and further suggested that &ldquo;the same procedure could be used to implement VMAT RP models with different dose prescription protocols.&rdquo;The study initially selected 100 VMAT-based breast plans to construct a breast left and a breast right <a href="https://www.docwirenews.com/gu-oncology-now/reduction-of-systematic-dosimetric-uncertainties-in-volumetric-modulated-arc-therapy-triggered-by-patient-specific-quality-assurance/">knowledge-based VMAT model</a> using RP. The RP models were verified &ldquo;based on goodness-of-fit statistics using the coefficients of determination (R2) and Chi-square (&chi;2), and the goodness-of-estimation statistics through the mean square error (MSE).&rdquo; The two RP models were then validated by reoptimizing 20 plans that integrated the models and 20 plans that did not. Dosimetrical parameters were used to compare MP and RP plans for treatment locations including heart, homolateral lung, contralateral lung, and contralateral breast.The least favorable R2 results for the RP models were 0.51 for contralateral lung in RP-right breast (RP-RB) and 0.60 for heart in RP-left breast (RP-RB); While the most unfavorable &chi;2 results were 1.02 for contralateral breast in RP-RB and 1.03 for heart in RP-LB. Additionally, the study&rsquo;s authors reported that no overfitting occurred, no unfavorable mean square error (MSE) results were found, and estimation power was strong in both RP models.Given their validation findings, the study&rsquo;s collaborators advanced that &ldquo;the use of RP models generates high-quality plans, without differences from the planner experience&rdquo; in planning volumetric modulated arc therapy treatments for <a href="https://www.docwirenews.com/gu-oncology-now/effects-of-mechanical-performance-on-deliverability-and-dose-distribution-by-comparing-multi-institutions-knowledge-based-models-for-prostate-cancer-in-volumetric-modulated-arc-therapy/">patients with breast cancer</a>. They did acknowledge, however, that &ldquo;longer time and experience in the use of RP are necessary to confirm the results shown in this study.&rdquo;

Jordana Jampel

Positive Preliminary Results From Phase 1 Trial of Dopaminergic Neuron Graft for Parkinson’s Disease

Dementia

Bradley Warady, MD

Joel M. Topf, MD, FACP

2025 Hume Award Winner Is Dedicated to Children’s Care

NKF Spring Clinical Meetings 2025

Distant Brain Metastases in Cutaneous Melanoma May Be Mitigated With Multiple Pathway Inhibitors

Melanoma

Latest News

Constructing a Planning Model for Volumetric Modulated Arc Therapy in the Treatment of Breast Cancer

Breast Cancer News

Researchers from the Department of Medical Physics at Instituto Zunino - Fundación Marie Curie in Córdoba, Argentina, set out to construct a knowledge-based volumetric ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe